A Priori Predictive Performance of Four Model-Informed Precision Dosing Software Programs for Vancomycin in Hospitalized Patients: A Single-Center Retrospective Study

Abstract Purpose We aimed to evaluate the a priori predictive performance of four model-informed precision dosing (MIPD) software programs and identify factors associated with prediction error in inpatients receiving vancomycin. Methods We retrospectively included patients who received intravenous vancomycin and underwent therapeutic drug monitoring (TDM). C min , C max , and AUC 0−24 were predicted using SmartDose, PharmVAN, NextDose, and IOA. Performance was evaluated by prediction error (PE), absolute prediction error (APE), F30 (proportion of APE ≤ 30%), root mean square error (RMSE), and classification agreement rate (CAR). For the best-performing program, multivariable generalized linear modeling (GLM) identified factors associated with AUC 0−24 APE. Results IOA demonstrated the most favorable overall performance. Its median APE and F30 were 29.8% and 51.0% for C min ; 15.3% and 77.6% for C max ; and 20.9% and 70.9% for AUC 0−24 , respectively. IOA also had the lowest RMSEs (7.74 mg/L, 10.86 mg/L, and 202.68 mg·h/L) and the largest relative radar-chart area (58.9%). Acute kidney injury (AKI; Exp( B ) = 2.103, P = 0.024) and low daily dose (< 2 g/day; Exp( B ) = 1.498, P = 0.030) were independently associated with greater AUC 0−24 APE. Patients with AKI had lower F30 (20.0% vs 73.7%) and higher RMSE (507.16 vs 171.64 mg·h/L) than those without. Conclusions IOA showed relatively favorable a priori performance, but errors persisted, particularly in patients with AKI. A priori predictions should be interpreted cautiously in unstable renal function, and early TDM incorporation is recommended for Bayesian updating.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11553704/v1
Primary Topic
Antibiotics Pharmacokinetics and Efficacy
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

A Priori Predictive Performance of Four Model-Informed Precision Dosing Software Programs for Vancomycin in Hospitalized Patients: A Single-Center Retrospective Study

Guohua Zhou, Qiao Wang, Xuejiao Liu, Yumeng Li et al.
Research Square
Antibiotics Pharmacokinetics and Efficacy
preprint

A Priori Predictive Performance of Four Model-Informed Precision Dosing Software Programs for Vancomycin in Hospitalized Patients: A Single-Center Retrospective Study

Guohua Zhou, Qiao Wang, Xuejiao Liu, Yumeng Li, YunJuan Zhao, HaiPing Wu, JiaXing Wei, XinYan Bai
preprint en

Abstract

Abstract Purpose We aimed to evaluate the a priori predictive performance of four model-informed precision dosing (MIPD) software programs and identify factors associated with prediction error in inpatients receiving vancomycin. Methods We retrospectively included patients who received intravenous vancomycin and underwent therapeutic drug monitoring (TDM). C min , C max , and AUC 0−24 were predicted using SmartDose, PharmVAN, NextDose, and IOA. Performance was evaluated by prediction error (PE), absolute prediction error (APE), F30 (proportion of APE ≤ 30%), root mean square error (RMSE), and classification agreement rate (CAR). For the best-performing program, multivariable generalized linear modeling (GLM) identified factors associated with AUC 0−24 APE. Results IOA demonstrated the most favorable overall performance. Its median APE and F30 were 29.8% and 51.0% for C min ; 15.3% and 77.6% for C max ; and 20.9% and 70.9% for AUC 0−24 , respectively. IOA also had the lowest RMSEs (7.74 mg/L, 10.86 mg/L, and 202.68 mg·h/L) and the largest relative radar-chart area (58.9%). Acute kidney injury (AKI; Exp( B ) = 2.103, P = 0.024) and low daily dose (< 2 g/day; Exp( B ) = 1.498, P = 0.030) were independently associated with greater AUC 0−24 APE. Patients with AKI had lower F30 (20.0% vs 73.7%) and higher RMSE (507.16 vs 171.64 mg·h/L) than those without. Conclusions IOA showed relatively favorable a priori performance, but errors persisted, particularly in patients with AKI. A priori predictions should be interpreted cautiously in unstable renal function, and early TDM incorporation is recommended for Bayesian updating.

Research Square
Nanjing University of Chinese Medicine (CN), Nanjing Medical University (CN), Nanjing University (CN)
Good health and well-being
Antibiotics Pharmacokinetics and Efficacy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon